
Taiwo Oladapo
Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )
| Most Active Art Unit | 1771 |
| Art Unit(s) | 1797, 1771 |
| Total Applications | 1276 |
| Issued Applications | 617 |
| Pending Applications | 137 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7422380
[patent_doc_number] => 20040229293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Surface receptor complexes as biomarkers'
[patent_app_type] => new
[patent_app_number] => 10/812619
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 27071
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10812619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/812619 | Surface receptor complexes as biomarkers | Mar 29, 2004 | Abandoned |
Array
(
[id] => 7034182
[patent_doc_number] => 20050032692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Methods of inhibiting tumor cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 10/809144
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27461
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032692.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809144
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809144 | Methods of inhibiting tumor cell proliferation | Mar 24, 2004 | Issued |
Array
(
[id] => 5188004
[patent_doc_number] => 20070166312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Antibody against tumor specific antigen as target'
[patent_app_type] => utility
[patent_app_number] => 10/548688
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30793
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548688
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548688 | Antibody against tumor specific antigen as target | Mar 8, 2004 | Issued |
Array
(
[id] => 5595771
[patent_doc_number] => 20060159687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Modified aerolysin and methods of use for treating lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/547528
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17210
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159687.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547528 | Modified aerolysin and methods of use for treating lung cancer | Mar 1, 2004 | Abandoned |
Array
(
[id] => 5608405
[patent_doc_number] => 20060269921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Methods of diagnosis and prognosis of pancreatic cancer'
[patent_app_type] => utility
[patent_app_number] => 10/548460
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 62757
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10548460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/548460 | Methods of diagnosis and prognosis of pancreatic cancer | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7405466
[patent_doc_number] => 20040175758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Novel Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders'
[patent_app_type] => new
[patent_app_number] => 10/772656
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29435
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772656 | Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders | Feb 4, 2004 | Issued |
Array
(
[id] => 813834
[patent_doc_number] => 07414108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Composition and method for producing an immune response against tumor-related antigens'
[patent_app_type] => utility
[patent_app_number] => 10/772856
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6668
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/414/07414108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772856 | Composition and method for producing an immune response against tumor-related antigens | Feb 3, 2004 | Issued |
Array
(
[id] => 7261079
[patent_doc_number] => 20040241088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for evaluating the efficacy of certain cancer treatments'
[patent_app_type] => new
[patent_app_number] => 10/765568
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11356
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10765568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/765568 | Method for evaluating the efficacy of certain cancer treatments | Jan 27, 2004 | Abandoned |
Array
(
[id] => 5739239
[patent_doc_number] => 20060009630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Compositions and methods for inhibiting squamous cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 10/766317
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19343
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10766317
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/766317 | Compositions and methods for inhibiting squamous cell carcinoma | Jan 26, 2004 | Issued |
Array
(
[id] => 7033625
[patent_doc_number] => 20050032134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Neoplasm-specific polypeptides and their uses'
[patent_app_type] => utility
[patent_app_number] => 10/764730
[patent_app_country] => US
[patent_app_date] => 2004-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 26330
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764730 | Neoplasm-specific polypeptides and their uses | Jan 25, 2004 | Issued |
Array
(
[id] => 5631461
[patent_doc_number] => 20060147930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Amplified and overexpressed gene in colorectal cancers'
[patent_app_type] => utility
[patent_app_number] => 10/539868
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16743
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539868 | Amplified and overexpressed gene in colorectal cancers | Jan 14, 2004 | Abandoned |
Array
(
[id] => 5873976
[patent_doc_number] => 20060166212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Breast specific protein expressed in cancer and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/540310
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13273
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166212.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540310
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540310 | Breast specific protein expressed in cancer and methods of use thereof | Dec 18, 2003 | Abandoned |
Array
(
[id] => 7010265
[patent_doc_number] => 20050063981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/729340
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11069
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20050063981.pdf
[firstpage_image] =>[orig_patent_app_number] => 10729340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/729340 | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof | Dec 3, 2003 | Issued |
Array
(
[id] => 5821064
[patent_doc_number] => 20060025377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Inhibitor of angiogenesis and kit for treating cancer comprising the inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/537319
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4817
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537319 | Inhibitor of angiogenesis and kit for treating cancer comprising the inhibitor | Nov 30, 2003 | Abandoned |
Array
(
[id] => 4497331
[patent_doc_number] => 07919083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms'
[patent_app_type] => utility
[patent_app_number] => 10/712398
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3092
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712398 | Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms | Nov 13, 2003 | Issued |
Array
(
[id] => 170266
[patent_doc_number] => 07662579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Cytogenetically determined prognosis of myeloma'
[patent_app_type] => utility
[patent_app_number] => 10/705134
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6320
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662579.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705134 | Cytogenetically determined prognosis of myeloma | Nov 9, 2003 | Issued |
Array
(
[id] => 5710473
[patent_doc_number] => 20060051818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 10/530568
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8759
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530568 | Method for NGF assay for in vitro diagnosis of breast cancer and therapeutic use | Oct 27, 2003 | Issued |
Array
(
[id] => 7387881
[patent_doc_number] => 20040082772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/678140
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21331
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10678140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/678140 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Oct 5, 2003 | Abandoned |
Array
(
[id] => 6977812
[patent_doc_number] => 20050287530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'TCL-1b gene and protein and related methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 10/678790
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24017
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 60
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287530.pdf
[firstpage_image] =>[orig_patent_app_number] => 10678790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/678790 | TCL-1b gene and protein and related methods and compositions | Oct 1, 2003 | Abandoned |
Array
(
[id] => 5767700
[patent_doc_number] => 20060019320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Wnt mediated erbb signalling, compositions and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/528439
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9599
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528439 | Wnt mediated erbb signalling, compositions and uses related thereto | Sep 18, 2003 | Abandoned |